Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko Ishibashi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2024
[Immune microenvironment and immunotherapy resistance in multiple myeloma]Mariko Ishibashi
Cancers|January 16, 2021
Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple MyelomaMariko Ishibashi, Rimpei Morita, Hideto Tamura
Leukemia Research|July 16, 2011
Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironmentMariko Ishibashi, Hideto Tamura, Kiyoyuki Ogata
Biochemical and Biophysical Research Communications|January 16, 2010
2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitroMariko Ishibashi, Takaji Wakita, Mariko Esumi
Life (Basel, Switzerland)|August 26, 2023
Current and Future PET Imaging for Multiple MyelomaMariko Ishibashi, Miwako Takahashi, Taiga Yamaya, et al.
Cancers|December 18, 2019
Immunotherapy for Multiple MyelomaHideto Tamura, Mariko Ishibashi, Mika Sunakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[SLAM family proteins as therapeutic targets in multiple myeloma]Hideto Tamura, Mariko Ishibashi, Hidemi Takahashi, et al.
Cancers|April 16, 2020
PD-L1-PD-1 Pathway in the Pathophysiology of Multiple MyelomaHideto Tamura, Mariko Ishibashi, Mika Sunakawa-Kii, et al.
Archives of Virology|June 27, 2014
CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfectionMariko Ishibashi, Naoko Morita, Chisato Nomura-Kawaguchi, et al.
Experimental and Molecular Pathology|June 18, 2013
β-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological liversHiromi Yamaguchi, Sawako Matsumoto, Mariko Ishibashi, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2024
[Immune microenvironment and immunotherapy resistance in multiple myeloma]Mariko Ishibashi
Cancers|January 16, 2021
Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple MyelomaMariko Ishibashi, Rimpei Morita, Hideto Tamura
Leukemia Research|July 16, 2011
Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironmentMariko Ishibashi, Hideto Tamura, Kiyoyuki Ogata
Biochemical and Biophysical Research Communications|January 16, 2010
2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitroMariko Ishibashi, Takaji Wakita, Mariko Esumi
Life (Basel, Switzerland)|August 26, 2023
Current and Future PET Imaging for Multiple MyelomaMariko Ishibashi, Miwako Takahashi, Taiga Yamaya, et al.
Cancers|December 18, 2019
Immunotherapy for Multiple MyelomaHideto Tamura, Mariko Ishibashi, Mika Sunakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[SLAM family proteins as therapeutic targets in multiple myeloma]Hideto Tamura, Mariko Ishibashi, Hidemi Takahashi, et al.
Cancers|April 16, 2020
PD-L1-PD-1 Pathway in the Pathophysiology of Multiple MyelomaHideto Tamura, Mariko Ishibashi, Mika Sunakawa-Kii, et al.
Archives of Virology|June 27, 2014
CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfectionMariko Ishibashi, Naoko Morita, Chisato Nomura-Kawaguchi, et al.
Experimental and Molecular Pathology|June 18, 2013
β-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological liversHiromi Yamaguchi, Sawako Matsumoto, Mariko Ishibashi, et al.
Pageof 3